1. Home
  2. PASG vs RDI Comparison

PASG vs RDI Comparison

Compare PASG & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PASG
  • RDI
  • Stock Information
  • Founded
  • PASG 2017
  • RDI 1937
  • Country
  • PASG United States
  • RDI United States
  • Employees
  • PASG N/A
  • RDI N/A
  • Industry
  • PASG Biotechnology: Pharmaceutical Preparations
  • RDI Movies/Entertainment
  • Sector
  • PASG Health Care
  • RDI Consumer Discretionary
  • Exchange
  • PASG Nasdaq
  • RDI Nasdaq
  • Market Cap
  • PASG 27.6M
  • RDI 31.6M
  • IPO Year
  • PASG 2020
  • RDI N/A
  • Fundamental
  • Price
  • PASG $6.78
  • RDI $1.28
  • Analyst Decision
  • PASG Strong Buy
  • RDI
  • Analyst Count
  • PASG 4
  • RDI 0
  • Target Price
  • PASG $59.25
  • RDI N/A
  • AVG Volume (30 Days)
  • PASG 33.7K
  • RDI 18.5K
  • Earning Date
  • PASG 11-10-2025
  • RDI 11-12-2025
  • Dividend Yield
  • PASG N/A
  • RDI N/A
  • EPS Growth
  • PASG N/A
  • RDI N/A
  • EPS
  • PASG N/A
  • RDI N/A
  • Revenue
  • PASG N/A
  • RDI $219,213,000.00
  • Revenue This Year
  • PASG N/A
  • RDI $6.85
  • Revenue Next Year
  • PASG N/A
  • RDI $10.86
  • P/E Ratio
  • PASG N/A
  • RDI N/A
  • Revenue Growth
  • PASG N/A
  • RDI 7.59
  • 52 Week Low
  • PASG $5.12
  • RDI $1.17
  • 52 Week High
  • PASG $26.60
  • RDI $1.87
  • Technical
  • Relative Strength Index (RSI)
  • PASG 40.47
  • RDI 32.93
  • Support Level
  • PASG $6.16
  • RDI $1.34
  • Resistance Level
  • PASG $7.91
  • RDI $1.38
  • Average True Range (ATR)
  • PASG 0.57
  • RDI 0.05
  • MACD
  • PASG -0.16
  • RDI -0.01
  • Stochastic Oscillator
  • PASG 19.00
  • RDI 13.04

About PASG Passage Bio Inc.

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.

About RDI Reading International Inc

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.

Share on Social Networks: